<<

Dosage Compensation Mechanisms: Evolution Dosage Compensation Mechanisms: Evolution

Ignacio Marı´n, Universidad de Valencia, Valencia, Spain Advanced article Degeneration of sex-limited generates the need for dosage compensation Article contents mechanisms able to equalize in both sexes the amount of products derived from sex-linked . Evolution of these mechanisms is understood in some detail in the fly Drosophila Dosage Compensation Mechanisms: melanogaster,thenematodeCaenorhabditis elegans and in eutherian mammals. An Evolutionary Perspective Human Dosage Compensation in an Evolutionary Framework Relationships among Dosage Compensation Dosage Compensation Mechanisms: Systems: Common Origin or Convergence? An Evolutionary Perspective doi: 10.1038/npg.els.0006128

In many species, sex chromosomes that originated as expressed at very different levels, in different times and an identical, homologous pair currently show mor- places. However, all available data suggest that general phological differentiation in one of the sexes. An dosage compensation mechanisms are the rule, not the individual of the homogametic sex has two identical exception. We have molecular information for three sex chromosomes, whereas an individual of the dosage compensation systems, those of the fly heterogametic sex has two distinct chromosomes. Drosophila melanogaster, the nematode Caenorhabditis The restricted to the heterogametic sex elegans and eutherian mammalian species. In these often has a low number of genes. Loss of function three cases, the key feature is the existence of a mecha- is caused by the combined effect of chromosome nism able to modify transcriptional levels by modu- restriction to one sex (often due to the emergence of lating structure along whole chromosomes. a dominant sex-determining gene) and inhibition of A consideration of the mechanisms found in recombination with its homolog. Under these circum- protostome species is relevant here. In D. melanogaster, stances, mutations cannot be eliminated by recombi- females are the homogametic sex (XX), whereas males nation. They therefore accumulate, leading to the are heterogametic (XY). Dosage compensation occurs progressive loss of genetic function in a process via increased expression of X-linked genes in males. It known as chromosome degeneration (reviewed in is achieved by the action of a male-specific ribo- Charlesworth, 1996). (See Sex Chromosomes.) nucleoproteic complex, called a compensasome, that is When chromosome degeneration starts, a mechan- formed by at least five and two noncoding ism known as dosage compensation evolves to equalize . Compensasomes bind in hundreds of positions the levels of sex chromosome-derived products in both along the male . This binding correlates sexes. The discoverer of dosage compensation, H. J. with hypertranscription of X-linked genes. A known Muller, reasoned more than 50 years ago that once the biochemical function of the compensasome is its genes of a chromosome start accumulating mutations, contribution to the enrichment along the male X a progressive need arises to compensate for the loss chromosome of an acetylated isoform of histone H4 of their products. In particular, lowering by half the (acetylated at 16). One of the proteins of the products of genes required in similar levels in both sexes compensasome is a histone acetyltransferase. It is must lead to dysfunctions in the heterogametic sex. still unknown how compensasomes detect their bind- Thus, a dosage compensation mechanism is strongly ing targets on the X chromosome, although there is favored by natural selection. (See Muller, Herman evidence of ‘entry sites’, sequences that recruit com- Joseph.) pensasomes and from which the complexes would There are two ways of generating compensatory spread in cis. mechanisms. As the need for compensation arises in In C. elegans (hermaphrodites XX, males X0), gene parallel to mutation accumulation, and thus in prin- expression in both hermaphrodite X chromosomes is ciple gene-by-gene, independent solutions for each decreased by half. This is the result of the binding of gene could emerge. The alternative is the emergence of a complex of proteins unrelated to those found in a general mechanism able to regulate a twofold the Drosophila compensasome. Which sequences are difference in the expression of many unrelated genes. detected on the X chromosomes for the complex to This option appears unlikely. Genes in a degenerating bind is not yet understood. As in Drosophila, chroma- chromosome are functionally diverse. They are often tin modification is thought to be critical. Two of the

ENCYCLOPEDIA OF LIFE SCIENCES & 2005, John Wiley & Sons, Ltd. www.els.net 1 Dosage Compensation Mechanisms: Evolution proteins of the C. elegans dosage compensation inactivation. A large noncoding RNA transcribed from complex belong to a family of proteins involved in the accumulates and ‘coats’ the future chromatin condensation in other processes, including inactive chromosome. The gene , involved in mitosis. However, how condensation is biochemically regulation of Xist function, is transcribed into another achieved is still unknown. noncoding RNA from the strand opposite Xist.AsTsix Comparison of these two systems reveals some overlaps with Xist, its RNA is antisense of the features that are relevant for understanding the origin Xist RNA (hence the peculiar name ‘Tsix’). The and evolution of the mammalian system: (1) compen- most current model suggests that Tsix expression sation is established by global modification of the antagonizes Xist expression, protecting one of the degree of compaction of sex chromosomes; (2) it requ- chromosomes from inactivation. Recently, the first ires the binding of trans-acting factors to sequences on trans-acting regulator has been found. The transcrip- the X chromosomes and (3) the trans-acting factors are tion factor CTCF binds Tsix. It has been suggested different in flies and nematodes, suggesting that these that CTCF binding occurs on only one of the two X mechanisms evolved independently. chromosomes, owing to methylation differences between Tsix alleles. Once CTCF binds and activates Tsix on an X chromosome, Xist function is inhibited, Human Dosage Compensation in allowing that chromosome to remain active (Chao et al., 2002). (See Noncoding RNAs: A Regulatory Role?; an Evolutionary Framework Nonprotein-coding Genes; X-chromosome Inactivation; X-chromosome Inactivation and Disease.) In most eutherian mammals, including humans, However, several lines of evidence suggest that females are the homogametic sex (XX) and males are models including only Xist and Tsix are insufficient. heterogametic (XY). The evolutionary history of For instance, the choice between X chromosomes for human sex chromosomes is complex. They originated inactivation is known to be influenced by the poorly as a pair of homologous that can be called understood X-controlling element (Xce), which is proto-X and proto-Y. At some moment after the split located nearby but does not overlap with Xist or Tsix. of the lineages (about 320 million years ago), the How Xist RNA spreads along the X chromosome is proto- became restricted to the male also not fully understood. In particular, what kind of sex, probably by the acquisition of a dominant male- cis-acting sequences contribute to this spreading has determining function. There is evidence that, 80–130 not been determined completely. An involvement of million years ago, regions of autosomal origin were LINE-1 repetitive elements has been suggested. These added to both the proto-X and proto-Y chromosomes. elements are enriched in the X chromosome. More- Several chromosomal inversions also occurred, lead- over, some genes are able to escape inactivation and, ing to different gene arrangements in the proto-X and in humans, are concentrated in the regions added most proto-Y, and progressively inhibiting recombination recently to the sex chromosomes. It has been suggested between them. The combination of sex-specific restric- that low concentrations of LINE-1 might define which tion and lack of recombination led to chromosome regions escape inactivation (Bailey et al., 2000). (See degeneration of the proto-Y. Mutations that arose on Long Interspersed Nuclear Elements (LINEs).) the proto-Y could not be eliminated by recombination Once Xist RNA coats an X chromosome, it is in the heterogametic sex. The proto-Y chromosome assumed that it recruits proteins, contributing to the progressively lost most of its genes and became the Y dramatic change in chromatin structure that follows. chromosome of today (Lahn and Page, 1999). (See Soon after Xist spreading, histones H3 and H4 become Chromosome Rearrangement Patterns in Mammalian hypoacetylated, the unusual histone macroH2A1 Evolution; Chromosome X; Chromosome Y; Mammalian accumulates, and gene promoters become hyper- Sex Chromosome Evolution.) methylated. Methylation of in its lysine 9 Dosage compensation in embryonic and adult residue, characteristic of in many tissues of eutherians is achieved by random inactiva- eucaryotic organisms, also occurs soon after Xist tion of one of the female X chromosomes. As coating, preceding transcriptional inactivation of happened in the protostome species discussed above, X-linked genes. This may be the first modification to this occurs by changes in chromosome condensation. appear on the future inactive X chromosome (Heard In eutherians, the change is radical: one of the female et al., 2001). It is likely that all of these modifications X chromosomes becomes highly compacted, or are directly or indirectly targeted to the X chromo- heterochromatic. It is still not fully understood how some by the presence of the Xist transcript. (See inactivation is achieved, but some of the main factors Histone Acetylation: Long-range Patterns in the Genome; in the process have been characterized. It is known Methylation-mediated Transcriptional Silencing in that the X-linked gene Xist is essential in cis for Tumorigenesis.)

2 Dosage Compensation Mechanisms: Evolution

Current data support a relatively ancient origin of co-opted when subsequent degenerative processes the inactivation-based mechanism. Xist has been occur. One example is the previously mentioned characterized in humans and rodents, having diverged addition of autosomal material to the proto-X and about 80 million years ago, and is known to exist in proto-Y chromosomes in mammals. A second example other eutherians. Moreover, female X-chromosome is the translocations between sex chromosomes and inactivation occurs also in marsupial mammals. In autosomes found in a few drosophilid fly species marsupials, inactivation is not random but, as also (Marı´n et al., 1996). happens in extraembryonic tissues in at least some In these two situations, degenerative processes eutherians (e.g. mouse), it is always the paternal X startedinnewchromosomalregions.Inbothcases,ithas chromosome that is inactivated. In addition, X been found that the range of action of the preexisting inactivation is incomplete in marsupials; different dosage compensation systems was expanded to include sets of paternal genes are inactivated in different those chromosomal regions. These results suggest that tissues. There is so far no evidence of gene orthologs reusing a dosage compensation system is simpler than of Xist or Tsix in these organisms. However, it is known finding a new way to dosage-compensate. that Xist evolves rapidly (Nesterova et al., 2001). Thus, However, these data are far from conclusive. First, the presence of an Xist-related gene in marsupials mechanistic similarities may be the result of conver- cannot be dismissed at present. It is therefore possible gence. Multiple processes require chromatin modula- that marsupial and eutherian dosage compensation tory changes that involve histone modifications, and systems, although somewhat different, have the same it is likely that any global system of origin. It is still unclear whether monotreme mammals regulation requires those modifications. In addition, have X-chromosome inactivation. The other organ- studies are increasingly detecting the involvement of isms for which some information exists are birds, noncoding RNAs in the regulation of gene expression where females are the heterogametic sex (ZW) and (Blencowe, 2002; Sleutels et al., 2002). (See Evolution: males are homogametic (ZZ). It is thought that these Convergent and Parallel; Noncoding RNAs: A Regulatory chromosomes also arose from a homomorphic pair of Role?) autosomes, although different from the one that It is unclear whether finding RNAs that are involved became the XY pair in mammals. Birds had previously in chromatin regulatory processes is as exceptional as been thought to lack dosage compensation. However, it seems today. The lack of similarity of the C. elegans recent data suggest that dosage compensation, at system to the other two mechanisms suggests that fully least for some Z-linked genes, exists (McQueen et al., innovative systems may emerge. Perhaps the main 2001). In any case, there is no evidence of argument in favor of independent origins of dosage Z-chromosome inactivation in birds. These data compensation mechanisms is historical. It is unlikely suggest that the X-inactivation mechanism originated that a species without heteromorphic chromosomes at least 130, but less than 320, million years ago. (See has dosage compensation. Thus, when two lineages Homologous, Orthologous and Paralogous Genes.) derive from such a species, there is no ancestral mechanism they must share. If dosage compensation arises, it is an independent occurrence. An example of Relationships among Dosage this may be the differences in the avian and mamma- lian lineages. Following this argument, it is notable Compensation Systems: Common that all cases in which dosage compensation mechan- Origin or Convergence? isms have been co-opted for new regions involve additions to preexisting heteromorphic sex chromo- The previous sections highlight the differences somes, but not degenerative processes started from among the dosage compensation systems in humans scratch on a homomorphic pair of chromosomes. That and those found in other species. However, the X-chromosome inactivation emerged in mammalian speculative idea that all dosage compensation systems species is still the most parsimonious hypothesis. found today in protostomes and deuterostomes may be variations of an ancestral mechanism has some See also indirect experimental support. First, functional simila- Chromosome X: General Features rities, in particular when Drosophila and mammals are Sex Chromosomes compared, clearly exist. Both Drosophila and mam- X-chromosome Inactivation and Disease malian dosage compensation systems require noncod- ing RNAs that spread along the sex chromosomes References and also involve covalent modifications of histones. Bailey JA, Carrel L, Chakravarti A and Eichler EE (2000) Molecular Second, data exist showing that, once a dosage evidence for a relationship between LINE-1 elements and X compensation mechanism has been established, it is chromosome inactivation: the Lyon repeat hypothesis.

3 Dosage Compensation Mechanisms: Evolution

Proceedings of the National Academy of Sciences of the United Cohen DE and Lee JT (2002) X-chromosome inactivation and the States of America 97: 6634–6639. search for chromosome-wide silencers. Current Opinion in Blencowe BJ (2002) Transcription: surprising role for an elusive Genetics and Development 12: 219–224. small nuclear RNA. Current Biology 12: R147–R149. Eddy SR (2001) Non-coding RNA genes and the modern RNA Chao W, Huynh KD, Spencer RJ, Davidow LS and Lee JT (2002) world. Nature Reviews Genetics 2: 919–929. CTCF, a candidate trans-acting factor for X-inactivation choice. Ellegren H (2002) Dosage compensation: do birds do it as well? Science 295: 345–347. Trends in Genetics 18: 25–28. Charlesworth B (1996) The evolution of chromosomal sex determi- Graves JAM and Shetty S (2001) Sex from W to Z: evolution of nation and dosage compensation. Current Biology 6: 149–162. vertebrate sex chromosomes and sex determining genes. Journal Heard E, Rougeulle C, Arnaud D, et al. (2001) Methylation of of Experimental Zoology 290: 449–462. histone H3 at Lys-9 is an early mark on the X chromosome Marı´n I, Siegal ML and Baker BS (2001) The evolution of dosage- during X inactivation. Cell 107: 727–738. compensation mechanisms. Bioessays 22: 1106–1114. Lahn BT and Page DC (1999) Four evolutionary strata on the Meller VH (2000) Dosage compensation: making 1X equal 2X. human X chromosome. Science 286: 964–967. Trends in Cell Biology 10: 54–59. Marı´n I, Franke A, Bashaw GJ and Baker BS (1996) The dosage Park Y and Kuroda MI (2001) Epigenetic aspects of X-chromosome compensation system of Drosophila is co-opted by newly evolved dosage compensation. Science 293: 1083–1085. X chromosomes. Nature 383: 160–163. McQueen HA, McBride D, Miele G, Bird AP and Clinton M (2001) Web Links Dosage compensation in birds. Current Biology 11: 253–257. Nesterova TB, Slobodyanyuk SY, Elisaphenko EA, et al. (2001) X (inactive)-specific transcript (XIST); LocusID: 7503. LocusLink: Characterization of the genomic Xist locus in rodents reveals http://www.ncbi.nlm.nih.gov/LocusLink/LocRpt.cgi?l ¼ 7503 conservation of overall gene structure and tandem repeats X (inactive)-specific transcript, antisense (TSIX); LocusID: 9383. but rapid evolution of unique sequence. Genome Research 11: LocusLink: 833–849. http://www.ncbi.nlm.nih.gov/LocusLink/LocRpt.cgi?l ¼ 9383 Sleutels F, Zwart R and Barlow DP (2002) The non-coding Air X (inactive)-specific transcript (XIST); MIM number: 314670. RNA is required for silencing autosomal imprinted genes. Nature OMIM: 415: 810–813. http://www.ncbi.nlm.nih.gov/htbin-post/Omim/ dispmim?314670 Further Reading X (inactive)-specific transcript, antisense (TSIX); MIM number: 300181. OMIM: Avner P and Heard E (2001) X-chromosome inactivation: counting, http://www.ncbi.nlm.nih.gov/htbin-post/Omim/ choice and initiation. Nature Reviews Genetics 2: 59–67. dispmim?300181

4